Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome
Crossref DOI link: https://doi.org/10.1007/s00277-015-2457-1
Published Online: 2015-07-29
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Piekarska, Agnieszka
Gil, Lidia
Prejzner, Witold
Wiśniewski, Piotr
Leszczyńska, Aleksandra
Gniot, Michał
Komarnicki, Mieczysław
Hellmann, Andrzej
License valid from 2015-07-29